
Selective growth-hormone secretagogue studied in GH-release research.

Sermorelin is a synthetic analog of GHRH (1-29). It has a short half-life and is studied for its effect on pituitary growth-hormone release.
Sermorelin has a clinical history in the diagnosis and treatment of pediatric growth-hormone deficiency. It also remains a research tool for studying the GH axis.
Published work spans clinical and laboratory settings, with different routes and schedules. Use the source paper’s methods section for the design being studied.
These notes are a starting point, not a laboratory protocol or medical guidance. Check the primary sources, your institution’s procedures, and applicable regulations before planning any work.